Source: International Congress 2017 – Infection and exacerbation science
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Papakonstantinou (Thessaloniki, Greece). Hyaluronic acid, heparan sulfate and chondroitin sulfate are altered during exacerbations of COPD. 994

Member's Comments

No comment yet.

Related content which might interest you: Serum heparan sulfate levels predict the etiology of acute exacerbations in COPD Source: Virtual Congress 2021 – Respiratory infections and bronchiectasis outcomes Year: 2021 Matrix proteoglycans as effector molecules for epithelial cell function Source: Eur Respir Rev 2005; 14: 137-144 Year: 2005 Diaphragm dysfunction in chronic obstructive pulmonary disease: a role for heparan sulphate? Source: Eur Respir J 2007; 30: 80-89 Year: 2007 Perlecan and heparan sulphate are abundant in fibroblast foci in Idiopathic Pulmonary Fibrosis. Source: International Congress 2017 – Novel pro- and anti-fibrotic mechanisms in pulmonary fibrosis Year: 2017 Predictors for significant changes in serum sulfated glycosaminoglycans at COPD exacerbations Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair Year: 2019 IL-8 and heparan sulphate expression are increased in CF compared to normal airway tissue Source: Eur Respir J 2001; 18: Suppl. 33, 106s Year: 2001 Hyaluronic acid in COPD exacerbations of different etiology Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases Year: 2020 Fine structural modifications of heparan sulfate sulfation patterns in lung are associated with functional effects in Precapillary Pulmonary Hypertension Source: International Congress 2018 – Pathobiology of pulmonary hypertension Year: 2018 Alterations in the expression of proteoglycans and glycosaminoglycans in pulmonary hypertension Source: Eur Respir J 2006; 28: Suppl. 50, 659s Year: 2006 Attacking the NE+ exosome with protamine sulfate effectively attenuates ECM remodeling in a COPD mouse model Source: International Congress 2019 – Injury and repair: less is more Year: 2019 Acute exacerbations in COPD patients are associated with increased levels of hyaluronic acid and heparan sulfate in BAL Source: International Congress 2014 – Translational studies in COPD Year: 2014 Hyaluronic acid is significantly increased in idiopathic pulmonary fibrosis Source: Eur Respir J 2006; 28: Suppl. 50, 604s Year: 2006 Alterations of systemic hyaluronic acid in patients with COPD: a cross-sectional analysis Source: Virtual Congress 2021 – Novel insights into the pathogenesis of chronic lung diseases Year: 2021 Efficiency of nebulised magnesium sulphate in exacerbations of chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 214s Year: 2006 The value of magnesium sulfate nebulization in treatment of acute bronchial asthma during pregnancy Source: Annual Congress 2012 - Trials in asthma: asthma exacerbations and severe asthma Year: 2012 Changes in xylosyltransferase activity and in proteoglycan deposition in bleomycin-induced lung injury in rat Source: Eur Respir J 2001; 18: 347-356 Year: 2001 Low dehydroepiandrosterone sulfate (DHEA-S) is associated with worse lung function in women. Source: International Congress 2018 – Respiratory epidemiology: from COPD to factors that associate with lung function and infections Year: 2018 The role of glycosaminoglycans in respiratory disease Source: Annual Congress 2009 - Pressure for plasticity: the pulmonary interstitium in the diseased lung Year: 2009 Differences in proteoglycan deposition in the airways of moderate and severe asthmatics Source: Eur Respir J 2007; 29: 71-77 Year: 2007 Occupational asthma to quaternary ammonium compounds: Clinical features of 16 positive bronchial challenge tests using didecyl dimethyl ammonium chloride Source: Annual Congress 2012 - Respiratory diseases at at work: epidemiology, inflammation and challenge studies Year: 2012